Sign in
TerminatedNo phase

Mechanisms of Exacerbation of Asthma

Key facts

Who runs it
University of California, San Francisco
Where
San Francisco, United StatesSee the site
Trial code
Status
Terminated
People taking part
67 people enrolled
Started
May 2006
Ended
5 Aug 2025
Type of study
Observational
Record updated
9 March 2026
Why it stopped
The restrictions on research imposed for the COVID-19 pandemic prevented us from continuing recruitment and visits. Funding was not sufficient to continue the study.

Who can take part

Age
18 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (7)Hide the full registry criteria

Who can take part

  • Male and female subjects with a history of asthma between the ages of 18 to 75 years
  • Physician diagnosis of asthma
  • Currently experiencing an acute exacerbation of asthma. This exacerbation may be severe necessitating treatment in the emergency room, ICU, or hospital ward
  • Ability to provide informed consent

Who cannot take part

  • Use of recreational drugs in the 1 month preceding the study
  • Lung disease other than asthma
  • Females who are lactating or who are pregnant

Where in United States

  • UCSF Airway Clinical Research CenterSan Francisco, United States

About the trial

What the trial wants to find out

The purpose of this study is to identify the causes of asthma that were not previously suspected, to better understand the effects of inhaled steroids on asthma and to identify new way to treat asthma.

The group in the trial

  • Asthma

    People who have been diagnosed with Asthma

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
9 March 2026